Several studies have shown that HOXA10 can increase the growth and invasion of ovarian cancer cells [18,19,20], and that endometroid, clear cell and mucinous tumours (but not serous) express significantly higher levels of HOXA10 compared with normal ovarian tissue. The gene discussed is HOXA10; the disease is ovarian carcinoma.